NANNETTI, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 2.414
AS - Asia 1.197
EU - Europa 731
SA - Sud America 179
AF - Africa 169
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.710
Nazione #
US - Stati Uniti d'America 2.308
SG - Singapore 389
CN - Cina 294
IT - Italia 262
VN - Vietnam 135
BR - Brasile 115
HK - Hong Kong 83
DE - Germania 77
FI - Finlandia 42
FR - Francia 41
IN - India 40
BD - Bangladesh 39
NL - Olanda 36
SE - Svezia 35
GB - Regno Unito 34
KR - Corea 30
RU - Federazione Russa 28
PL - Polonia 26
AR - Argentina 15
IQ - Iraq 15
JP - Giappone 15
AT - Austria 13
CA - Canada 13
IE - Irlanda 13
MX - Messico 13
CI - Costa d'Avorio 12
ES - Italia 11
TR - Turchia 11
UA - Ucraina 11
ZA - Sudafrica 11
MY - Malesia 10
PK - Pakistan 10
NI - Nicaragua 9
UZ - Uzbekistan 9
CL - Cile 8
PH - Filippine 8
PT - Portogallo 8
RE - Reunion 8
SA - Arabia Saudita 8
SN - Senegal 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
AM - Armenia 7
AU - Australia 7
BO - Bolivia 7
CR - Costa Rica 7
EG - Egitto 7
GR - Grecia 7
ID - Indonesia 7
KZ - Kazakistan 7
PY - Paraguay 7
BA - Bosnia-Erzegovina 6
CU - Cuba 6
DO - Repubblica Dominicana 6
EC - Ecuador 6
ET - Etiopia 6
GH - Ghana 6
GT - Guatemala 6
JO - Giordania 6
KE - Kenya 6
LC - Santa Lucia 6
MD - Moldavia 6
ME - Montenegro 6
MZ - Mozambico 6
RS - Serbia 6
CG - Congo 5
CH - Svizzera 5
CO - Colombia 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
HT - Haiti 5
IL - Israele 5
LU - Lussemburgo 5
MA - Marocco 5
NP - Nepal 5
PE - Perù 5
PR - Porto Rico 5
RW - Ruanda 5
SO - Somalia 5
UY - Uruguay 5
AF - Afghanistan, Repubblica islamica di 4
AZ - Azerbaigian 4
BE - Belgio 4
BF - Burkina Faso 4
BW - Botswana 4
BZ - Belize 4
CV - Capo Verde 4
CW - ???statistics.table.value.countryCode.CW??? 4
GA - Gabon 4
GE - Georgia 4
GF - Guiana Francese 4
HU - Ungheria 4
JM - Giamaica 4
KG - Kirghizistan 4
LB - Libano 4
LY - Libia 4
MK - Macedonia 4
ML - Mali 4
MN - Mongolia 4
MU - Mauritius 4
Totale 4.570
Città #
Fairfield 320
Singapore 237
Ashburn 229
San Jose 170
Woodbridge 155
Houston 153
Ann Arbor 151
Chandler 140
Seattle 121
Cambridge 113
Wilmington 101
Beijing 81
Hong Kong 75
Santa Clara 61
Boardman 36
Council Bluffs 36
Hanoi 36
Ho Chi Minh City 36
Los Angeles 36
San Diego 29
Helsinki 28
Hefei 27
Padova 25
Seoul 23
Milan 21
Munich 21
São Paulo 20
Medford 18
Princeton 18
Rome 18
Des Moines 16
Lauterbourg 16
New York 16
Bytom 15
Columbus 13
Frankfurt am Main 13
Roxbury 13
Abidjan 12
Da Nang 12
Dublin 12
Guangzhou 12
Tokyo 12
Buffalo 11
Orem 10
Pune 10
Managua 9
Nanjing 9
Shanghai 9
Stockholm 9
Dakar 8
Dearborn 8
Warsaw 8
Amsterdam 7
Baghdad 7
Naples 7
Tashkent 7
Vienna 7
Yerevan 7
Accra 6
Addis Ababa 6
Cagliari 6
Chicago 6
Havana 6
Johannesburg 6
Kuala Lumpur 6
Manchester 6
Maputo 6
Nairobi 6
Perugia 6
San José 6
Amman 5
Athens 5
Castries 5
Chennai 5
Chisinau 5
Dong Ket 5
Hargeisa 5
Kharkiv 5
Kigali 5
Madrid 5
Montevideo 5
Montreal 5
New Delhi 5
Padua 5
Podgorica 5
Toronto 5
Almaty 4
Atlanta 4
Baku 4
Bamako 4
Boston 4
Brooklyn 4
Guatemala City 4
Lahore 4
London 4
Muscat 4
Nuremberg 4
Ouagadougou 4
Port-au-Prince 4
Sanaa 4
Totale 3.038
Nome #
Sviluppo e caratterizzazione di nuovi inibitori diretti contro la polimerasi dei virus dell'influenza di tipo A e B 454
4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling 358
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 285
Antiviral strategies against influenza virus: towards new therapeutic approaches. 278
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin 274
A Broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic protein 1 (PA-PB1) subunits 272
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication 259
Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction 257
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 249
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly. 243
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 242
A sensitive and validated HPLC-UV method for the quantitative determination of the new antifungal drug isavuconazole in human plasma 236
Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma 235
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase 235
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 225
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 216
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds 214
Corrigendum to “Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity” [Eur. J. Med. Chem. 138 (2017) 128–139] (S0223523417304610) (10.1016/j.ejmech.2017.06.015)) 195
New dengue virus inhibitors targeting NS3-NS5 interaction identified by in silico screening 43
Totale 4.770
Categoria #
all - tutte 12.869
article - articoli 11.846
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.715


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021102 0 0 0 0 0 0 0 0 0 0 56 46
2021/2022332 8 58 28 29 41 21 18 34 9 11 16 59
2022/2023328 47 41 5 38 63 31 4 33 30 5 25 6
2023/2024234 3 32 26 13 30 22 41 16 3 20 16 12
2024/2025623 4 63 46 37 80 21 27 54 47 21 100 123
2025/20262.029 145 184 233 335 190 100 254 157 206 130 95 0
Totale 4.770